Literature DB >> 16325683

Are we losing artemisinin combination therapy already?

Patrick E Duffy1, Carol Hopkins Sibley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16325683     DOI: 10.1016/S0140-6736(05)67768-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  An analytical model for genetic hitchhiking in the evolution of antimalarial drug resistance.

Authors:  Kristan A Schneider; Yuseob Kim
Journal:  Theor Popul Biol       Date:  2010-06-19       Impact factor: 1.570

2.  Absorption, distribution, excretion, and pharmacokinetics of 14C-pyronaridine tetraphosphate in male and female Sprague-Dawley rats.

Authors:  Sang Hyun Park; Kannampalli Pradeep
Journal:  J Biomed Biotechnol       Date:  2010-03-31

Review 3.  The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum.

Authors:  Ananias A Escalante; David L Smith; Yuseob Kim
Journal:  Trends Parasitol       Date:  2009-10-26

4.  Analyzing Thiol-Dependent Redox Networks in the Presence of Methylene Blue and Other Antimalarial Agents with RT-PCR-Supported in silico Modeling.

Authors:  J Zirkel; A Cecil; F Schäfer; S Rahlfs; A Ouedraogo; K Xiao; S Sawadogo; B Coulibaly; K Becker; T Dandekar
Journal:  Bioinform Biol Insights       Date:  2012-12-03

5.  Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania.

Authors:  Kefas Mugittu; Blaise Genton; Hassan Mshinda; Hans Peter Beck
Journal:  Malar J       Date:  2006-12-19       Impact factor: 2.979

Review 6.  Monitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in Tanzania.

Authors:  Alex Shayo; Joram Buza; Deus S Ishengoma
Journal:  Malar J       Date:  2015-03-29       Impact factor: 2.979

7.  Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children.

Authors:  Adoke Yeka; Valerie Lameyre; Kibuuka Afizi; Mudangha Fredrick; Robinson Lukwago; Moses R Kamya; Ambrose O Talisuna
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

8.  Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients.

Authors:  Eva Maria Staehli Hodel; Monia Guidi; Boris Zanolari; Thomas Mercier; Socheat Duong; Abdunoor M Kabanywanyi; Frédéric Ariey; Thierry Buclin; Hans-Peter Beck; Laurent A Decosterd; Piero Olliaro; Blaise Genton; Chantal Csajka
Journal:  Malar J       Date:  2013-07-10       Impact factor: 2.979

9.  Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial.

Authors:  Boubacar Coulibaly; Augustin Zoungrana; Frank P Mockenhaupt; R Heiner Schirmer; Christina Klose; Ulrich Mansmann; Peter E Meissner; Olaf Müller
Journal:  PLoS One       Date:  2009-05-05       Impact factor: 3.240

10.  Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso.

Authors:  Augustin Zoungrana; Boubacar Coulibaly; Ali Sié; Ingeborg Walter-Sack; Frank P Mockenhaupt; Bocar Kouyaté; R Heiner Schirmer; Christina Klose; Ulrich Mansmann; Peter Meissner; Olaf Müller
Journal:  PLoS One       Date:  2008-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.